BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32224334)

  • 1. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
    Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
    Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
    Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
    Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
    Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
    Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
    Channar PA; Afzal S; Ejaz SA; Saeed A; Larik FA; Mahesar PA; Lecka J; Sévigny J; Erben MF; Iqbal J
    Eur J Med Chem; 2018 Aug; 156():461-478. PubMed ID: 30015078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
    Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
    Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFR
    Fadaly WAA; Nemr MTM; Kahk NM
    Bioorg Chem; 2024 Jun; 147():107403. PubMed ID: 38691909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases.
    Andleeb H; Hameed S; Ejaz SA; Khan I; Zaib S; Lecka J; Sévigny J; Iqbal J
    Bioorg Chem; 2019 Jul; 88():102893. PubMed ID: 30986550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antimicrobial, antioxidant, cytotoxic, antiurease and molecular docking studies of N-(3-trifluoromethyl)benzoyl-N'-aryl thiourea derivatives.
    Maalik A; Rahim H; Saleem M; Fatima N; Rauf A; Wadood A; Malik MI; Ahmed A; Rafique H; Zafar MN; Riaz M; Rasheed L; Mumtaz A
    Bioorg Chem; 2019 Jul; 88():102946. PubMed ID: 31054433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
    Abdel-Maksoud MS; Mohamed Hassan R; Abdel-Sattar El-Azzouny A; Nabil Aboul-Enein M; Oh CH
    Bioorg Chem; 2021 Dec; 117():105424. PubMed ID: 34678604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety.
    Abdel-Maksoud MS; El-Gamal MI; Gamal El-Din MM; Oh CH
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):97-109. PubMed ID: 30362383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP.
    Carozza JA; Brown JA; Böhnert V; Fernandez D; AlSaif Y; Mardjuki RE; Smith M; Li L
    Cell Chem Biol; 2020 Nov; 27(11):1347-1358.e5. PubMed ID: 32726585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors.
    Sun J; Lv XH; Qiu HY; Wang YT; Du QR; Li DD; Yang YH; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():1-9. PubMed ID: 23933045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of Novel Pyrazole Sulfonamide Derivatives as Potential AHAS Inhibitors.
    Lv XH; Ren ZL; Liu H; Li HD; Li QS; Wang L; Zhang LS; Yao XK; Cao HQ
    Chem Pharm Bull (Tokyo); 2018; 66(4):358-362. PubMed ID: 29607900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.